Previously we showed that activation of the Nucleus of the Solitary Tract (NTS)-Nucleus Paragigantocellularis (PGi)-Locus coeruleus (LC) pathway, which theoretically culminates with norepinephrine (NE) release in dorsal hippocampus (CA1 region) and basolateral amygdala (BLA) is necessary for the consolidation of object recognition (OR) memory. Here we show that, while the microinjection of the beta-noradrenergic receptor blocker timolol into CA1 impairs OR memory consolidation, the microinjection of norepinephrine (NE) promotes the persistence of this type of memory. Further, we show that OR consolidation is attended by an increase of norepinephrine (NE) levels and of the expression of brain derived neurotrophic factor (BDNF) in hippocampus, which are impaired by inactivation of the NTS-PGi-LC pathway by the infusion of muscimol into the NTS.
Introduction
It is known that emotionally arousal-induced memory consolidation requires noradrenergic activation of the basolateral amygdala (BLA) (Beldjoud, Barsegyan, & Roozendaal, 2015; McGaugh, 2000) as studied in inhibitory avoidance (IA) and other tasks (Beldjoud et al., 2015; McGaugh, 2015) . Previous research strongly suggests that the NE release in the BLA during the consolidation of emotional memories depends on arousal induced by activation of the NTS (Nucleus of the Solitary Tract)-PGi (Paragigantocellularis nucleus)-LC (Locus Coeruleus)-BLA pathway: Garcia-Medina and Miranda (2013) found that stimulation of the NTS promotes the release of NE in lateral and basolateral amygdala, and Roozendaal, Williams, and McGaugh (1999) showed that the activation of glucocorticoid receptors in NTS facilitates memory consolidation of inhibitory avoidance learning, among other researches. This pathway (NTS-PGi-LC) was proposed to play a major role in the modulation of the consolidation of aversive behaviors by Cedric Williams, James McGaugh and their associates over 20 years ago (Clayton and Williams, 2000a,b; King & Williams, 2009; Miyashita & Williams, 2004; Williams & McGaugh, 1993) and was suggested to play a similar role in that of OR by two of the present authors two years ago (Mello-Carpes & Izquierdo, 2013) .
Previously, our group demonstrated that basolateral and central amygdala noradrenergic activation is not necessary to promote object recognition task (OR) consolidation (Mello-Carpes & Izquierdo, 2013) , although others had shown that the noradrenergic activation of basolateral amygdala can modulate the consolidation of this memory (Roozendaal, Castello, Vedana, Barsegyan, & McGaugh, 2008) . OR memory is viewed as a relatively nonemotional declarative memory; however, considering that there is a lot of variability across OR procedures among different studies it is not easy to draw a meaningful conclusion about this. However, all OR task protocols do involve the presentation of novelty to the animal, and the detection of and reaction to novelty are major functions of the hippocampus (Acquas, Wilson, & Fibiger, 1996; Menezes et al., 2015; Netto et al., 1985) , we hypothesized that this type of memory may also require the participation of this pathway, but using taking as the last stage hippocampal noradrenergic activation, instead of that of the amygdala. In a previous paper (Mello-Carpes & Izquierdo, 2013) we showed that, although the connection of the medullary nuclei to the amygdala is not involved in OR consolidation, the connection of NTS-PGi-LC pathway to hippocampus is. Indeed, other evidences from previous works indicates an important role of the hippocampus in the consolidation of this task (Balderas, Rodriguez-Ortiz, & Bermudez-Rattoni, 2015; Clarke, Cammarota, Gruart, Izquierdo, & Delgado-García, 2010; Cohen & Stackman, 2015; Furini et al., 2010; Myskiw et al., 2008) .
In addition to our previous data, here we show that, while the hippocampal CA1 injection of b-adrenergic blocker timolol impairs OR memory consolidation, the injection of NE promotes the persistence of this memory. The LC stimulation, which culminates with the increase of NE release in hippocampus, promotes memory persistence too. Also, we demonstrate that OR learning promotes the hippocampal increase of NE levels, which are disrupted by inactivation of NTS-PGi-LC pathway after OR training. These results confirm the hippocampal noradrenergic modulation of OR memory.
Still, considering that recent findings suggest that OR consolidation requires an increase of BDNF expression in CA1 region of Fig. 1 . Experimental design. The experiments were organized in three stages. Experiment 1: The rats were habituated to the object recognition arena without any object for 4 days (20 min/day). In the training session rats were exposed to two different objects (A and B) for 5 min; immediately after that the received bilateral hippocampal infusions (1 ll/side in CA1) of vehicle (VEH; saline), timolol (TIM; 1 lg/ll for CA1) or norepinephrine (NE; 1 lg/ll) and, on the test session, realized 24 h after, animals were exposed to a familiar (A) and a novel object (C) for five minutes to evaluate long-term memory retention. Other group of animals received bilateral LC (Locus Coeruleus) infusions (0.25 ll/side) of vehicle (VEH; saline) or NMDA (NMDA; 0.1 lg/ll) or bilateral hippocampal infusions (1 ll/side in CA1) of vehicle (VEH; saline) or norepinephrine (NE; 1 lg/ll). On the test session, realized 21 days after, all animals were exposed to a familiar (A) and a novel object (C) for five minutes to evaluate long-term memory persistence.
Experiment 2: The rats were habituated to object recognition arena without any object for 4 days (20 min/day). On training session rats were exposed to two different objects (A and B) for 5 min and immediately after that received bilateral infusions (0.5 ll/side in NTS) of vehicle (VEH; saline) or muscimol (MUS 0.01 lg/ll); 15 min later the hippocampus were removed and prepared for HPLC determination of norepinephrine levels. Experiment 3: The rats were habituated to object recognition arena without any object for 4 days (20 min/day). On training session rats were exposed to two different objects (A and B) for 5 min and immediately after that received bilateral infusions of different drugs or combinations of drugs and/or vehicle in (MUS in NTS/PGi/LC; or MUS in NTS/PGi/LC + NE CA1; or MUS NTS/PGi + NMDA LC); 120 min later the hippocampus were removed and prepared for immunoblot determination of BDNF protein expression.
dorsal hippocampus 120 min after OR training (Furini et al., 2010) and that BDNF has an essential role in memory formation and persistence (Bekinschtein et al., 2008; Romero-Granados, FontanLozano, et al., 2010) we decided investigate the BDNF protein expression in hippocampus and demonstrated that it is disrupted when NTS-PGi-LC pathway is inactivated after OR training. The activation of a downstream point of the pathway after the inactivation, or the exogenous infusion of noradrenaline in hippocampus, or the stimulation of LC, however, permits the BDNF increase expect and necessary to OR learning.
Material and methods
Male Wistar rats (3-month-old, 350-380 g) purchased from FEPPS (Fundação Estadual de Produção e Pesquisa em Saúde do Rio Grande do Sul, Porto Alegre, Brazil) or from Central Vivarium of Federal University of Pelotas (RS/Brazil) were used. The animals were housed 5 to a cage and maintained with free access to food and water under a 12 h light-dark cycle, with lights on at 8:00 AM. The temperature of the animal room was kept at 22-24°C. All experiments were conducted in accordance with the ''Principles of laboratory animal care'' (NIH publication n°80-23, revised 1996) . Fig. 1 summarizes the experiments conducted.
Surgery and drug infusion procedures
In order to implant the rats with indwelling cannulas, they were deeply anesthetized with thiopental (i.p., 30-50 mg/kg) and 27-gauge cannulas were placed, stereotaxically aimed at the NTS (A -13.3, L ± 1.0, V -7.9 mm), PGi (A -12.8, L ± 1.6, V -12 mm), LC (A -9.7, L ± 1.3, V -7.1 mm) and/or CA1 region of the dorsal hippocampus (A -4.2, L ± 3.0, V -2.0 mm) (coordinates according to Paxinos and Watson (1986) . The cannulae were affixed with dental cement. Animals were allowed to recover from surgery for 4 days before submitting them to any other procedure. Some of the animals received bilateral cannulae implants into the NTS, PGi or LC and the CA1 region of the dorsal hippocampus; that is, they carried 4 brain cannulae each.
At the time of drug delivery, 30-gauge infusion cannulas were tightly fitted into the guides. Infusions (0.25 ll/side in LC, 0.5 ll/ side in NTS and PGi, and 1.0 ll/side in CA1 region of hippocampus)
were carried out over 60 s with an infusion pump, and the cannulas were left in place for 60 additional seconds to minimize backflow. The doses and volume used were based on pilot experiments and on previous studies showing the effect of each compound on learning and behavioral performance (Clayton & Williams, 2000a,b; Furini et al., 2010; Lemon, Aydin-Abidin, Funke, & ManahanVaughan, 2009; Mello-Carpes & Izquierdo, 2013) . The placement of cannulas was verified postmortem: 2-4 h after the last behavioral test, a 4% methylene-blue solution was infused in the same Norepinephrine is necessary to OR memory consolidation. On training session (day 1) rats were exposed to two different objects (A and B) for 5 min and immediately after that received bilateral infusions (1 ll/side in CA1) of vehicle (VEH; saline), timolol (TIM; 1 lg/ll for CA1) or norepinephrine (NE; 1 lg/ll). On test session (day 2), animals were exposed to a familiar (A) and a novel object (C) for five minutes to evaluate long-term memory retention. The infusion of b-adrenergic antagonist timolol in CA1 region of dorsal hippocampus immediately after training impairs retention of object recognition long-term memory. The infusion of NE in CA1 region of dorsal hippocampus immediately after training does not affect retention of object recognition long-term memory. Data (mean ± SD) are presented as percentage of total exploration time. ⁄ P 6 0.01 in one-sample Student's t-test with theoretical mean = 50; n = 9-12 per group.
Fig. 3.
Norepinephrine promotes OR memory persistence. On training session (day 1) rats were exposed to two different objects (A and B) for 5 min. In the first experiment (3A), immediately after training the rats received bilateral infusions
(1 ll/side in CA1) of vehicle (VEH; saline) or norepinephrine (NE; 1 lg/ll). In the second experiment (3B), immediately after training the rats received bilateral infusions (0.25 ll/side in LC) of vehicle (VEH; saline) or NMDA (NMDA; 0.1 lg/ll).
On test session (21 days later), animals were exposed to a familiar (A) and a novel object (C) for five minutes to evaluate long-term memory retention. Figure ( A) shows that the infusion of NE in CA1 region of dorsal hippocampus immediately after training promotes memory persistence of object recognition long-term memory. Fig. 2B shows that the induction of the increase of NE release on hippocampus through LC stimulation with NMDA promotes persistence of object recognition long-term memory. Data (mean ± SD) are presented as percentage of total exploration time. ⁄ P 6 0.01 in one-sample Student's t-test with theoretical mean = 50; n = 9-12 per group.
volume used in each of the mentioned places as described earlier, and the extension of the dye 30 min thereafter was taken as an indication of the presumable diffusion of the vehicle or drug previously given to each animal. Only data from animals with correct implants and no significant adjacent structure tissue spread were analyzed.
Drugs, antibodies and reagents
Muscimol (MUS), timolol (TIM), NMDA and NE were purchased from Sigma-Aldrich (St. Louis, MO). The drugs were dissolved in saline and stored at À20°C, protected from light until use, at which time an aliquot was thawed and diluted to working concentration in saline 0.9% (pH 7.2). The doses and volume used were based on a previous study of our laboratory and others, as cited before (MelloCarpes & Izquierdo, 2013) . Anti-BDNF and anti-tubulin antibody were from Santa Cruz Biotechnology (Santa Cruz, CA) and/or Sigma-Aldrich (St Louis, MO). Other reagents used in the experiments were of analytical grade and obtained from standard commercial suppliers.
Object recognition task
Training and testing in the object recognition task (OR) were carried out in an open-field arena (50 Â 50 Â 50 cm) built of polyvinyl chloride plastic, plywood and transparent acrylic as described previously (Ennaceur & Delacour, 1988; Mello-Carpes & Izquierdo, 2013) . The first procedure consisted in the habituation of the animals to the training box. Each animal was placed in the apparatus for 20 min of free exploration per day during 4 consecutive days before the training. On the training day, two different objects (A and B) were placed in the apparatus; animals were allowed to explore them freely for 5 min. The objects were made of metal, glass, or glazed ceramic. Exploration was defined as sniffing or touching the objects with the nose and/or forepaws. Sitting on or turning around the objects was not considered exploratory behavior. A video camera was positioned over the arena, and the rats' behavior was recorded using a video tracking and analysis system for later evaluation. The experiments were performed by an observer blind to the treatment condition of the animals.
In the experiments that involved a test session, this was carried out 24 h or 21 days later. One of the objects was randomly exchanged for a novel object (C) and rats were reintroduced into the apparatus for an additional 5 min period. To avoid confounds by lingering olfactory stimuli and preferences, the object and the arena were cleaned after testing each animal trial with 70% ethanol.
Norepinephrine levels
The determination of hippocampal NE levels was made by HPLC (High Performance Liquid Chromatography). Levels of NE in homogenates prepared from the hippocampus were determined using a reverse-phase HPLC system (YL9100, Young Lin). Rats' brains were removed and bilateral hippocampus were quickly dissected out in an iced surface and homogenized in 50 mM Tris HCl, pH 7.4, (1/10, w/v). Afterwards, samples were centrifuged at 2400g for 20 min, and supernatants were filtered and then stored at À80°C until use (Menezes et al., 2015; Nirogi et al., 2012) . The HPLC system consisted of a Vacuum Degasser (YL9101) and quaternary pump (YL9110) connected to a reversed phase column (SYNERGI 4l FUSION-RP 80 Å 250 Â 4.60 mm; Phenomenex) on a Column Compartment (YL9131) coupled to a Diode Array Detector (YL9160). The mobile phase consisted of methanol and water (12/88, v/v) adjusted to pH 3 with phosphoric acid. To separate NE, we used the programming isocratic with a flow rate of 0.8 mL/min. The sample was filtered through 0.22 lm syringe filters. We injected 20 lL samples into the HPLC system by an auto sampler device (YL9150). The detection was at 198 nm by DAD. Chromatograms were recorded and integrated by PC integration software (YLClarity). All analyses were run in triplicate. The analytical parameters were as follows: linear range, 0.1-10.0 lg/ml; determination coefficient, 0.999; and calibration equation, y = 628.12x À 34.342. Norepinephrine for HPLC was supplied by Sigma-Aldrich Brazil. Other reagents used in this experiment were of analytical grades and obtained from standard commercial suppliers.
Immunoblot essays to measure BDNF protein expression
Animals were killed by decapitation and the CA1 region of the dorsal hippocampus rapidly dissected out and homogenized in ice-chilled buffer (20 mM Tris-HCl, pH 7.4, 0.32 M sucrose, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 10 lg/ml aprotinin, 15 lg/ml leupeptin, 10 lg/ml bacitracin, 10 lg/ml pepstatin, 15 lg/ml trypsin inhibitor, 50 mM NaF, and 1 mM sodium orthovanadate). Protein concentration was determined using the BCA protein assay (Pierce, Rockford, IL), and equal amounts of protein were fractionated by SDS-PAGE before electrotransferred to polyvinylidene difluoride membranes (PVDF; Immobilon-P, Millipore, MS). After verification of protein loading by Ponceou S staining, the blots were blocked in Tween-Tris buffer saline (TTBS; 100 mm Tris-HCl, pH 7.5, containing 0.9% NaCl and 0.1% Tween 20) and incubated overnight with anti-BDNF antibody (N20, 1:5000, Santa Cruz Biotechnology, Santa Cruz, CA) or antitubulin antibody (1:1000, Sigma-Aldrich, St Louis, MO). The membranes were washed in TTBS and incubated with HRPcoupled anti-IgG antibody, washed again, and the immunoreactivity detected using a West-Pico enhanced chemiluminescence kit (Pierce, IL). Densitometric analysis was carried out in an ImageQuant RT-ECL system (GE, Piscataway, NJ). Fig. 4 . Consolidation of object recognition memory promotes a norepinephrine increase 15 min after training; NTS-PGi-LC pathway inhibition prevents this increase. Cannulated animals were habituated for 4 days (Hab) and some of them were trained in the OR task. Some animals were not exposed to OR apparatus (Naïve controls). Rats trained in the OR received an intra-NTS infusion of saline (Sal) or Muscimol (MUS) to promote the inhibition of NTS-PGi-LC-CA1 pathway and 15 min later were euthanized, and the bilateral hippocampus was removed for HPLC determination of NE levels. The tissue content of NE in the hippocampus homogenate (lg/ml) was higher in the trained rats infused by saline when compared to naïve or habituated ones. The tissue content of NE in the hippocampus homogenate (lg/ml) was lower in the trained rats infused by muscimol when compared to the ones that received saline. P < 0.01 (One-way ANOVA).
⁄ P < 0.01 for saline vs. naïve and saline vs. habituated. # P < 0.01 for saline vs. muscimol (Tukey's Multiple Comparison Test). n = 4 per group analyzed in triplicate.
Statistical analyses
Object exploration time in OR task was converted to percent of total exploration time and so a one-sample t-test was used to compare the percent of total time exploration spent in each object with a theoretical mean (50%). In HPLC results, the data of the groups were compared using an One-Way ANOVA followed by Tukey's Multiple Comparison Test. The immunoblots' data were analyzed using ANOVA followed by Dunnett's post hoc test. All data were expressed as mean ± SD. The sample size (n, number of animals in each group) for each experiment is stated in the figure legends. The differences were considered statistically significant at P < 0.05.
Results

Hippocampal norepinephrine is necessary for OR memory consolidation and can promotes memory persistence
To measure the effect of NE infusion into CA1, rats were trained in the OR learning task and immediately after training received bilateral intra-CA1 infusion of VEH, TIM or NE (1 lg/ll; 1 ll/side).
LTM was evaluated 24 h later. In the LTM retention test session, rats that received TIM were not able to remember the familiar object, and spent about the same time exploring each object ( Fig. 2 , P = 0.622), while the VEH rats spent significantly more than 50% of total exploration time exploring the novel object ( Fig. 2 , P < 0.0001). Rats that received NE after training explored the novel object significantly longer than the familiar one ( Fig. 2 , P = 0.006), similar to control (VEH) rats.
Considering these results we went on to investigate the effects of NE on OR memory persistence. Rats were trained in the OR task and tested them 21 days later. We did this in two conditions: (i) after a NE infusion directly into the CA1 region of dorsal hippocampus (Fig. 3A) , and (ii) after LC activation to promote increment of NE release in CA1 (Fig. 3B) . In both conditions we observed that the rats had their memory preserved 21 days after training, and spent more time exploring the novel object (P < 0.01), while the VEH rats were not able to recognize the new object, spending around 50% of total exploration time in each one. Fig. 5 . Consolidation of object recognition memory promotes a BNDF increase 120 min after training; this increase is blocked by infusion of muscimol in NTS (A), PGi (C) and LC (E). Consolidation of object recognition memory did not alter tubulin protein levels 120 min after training. Additionally, any alteration was seemed after infusion of muscimol in NTS (B), PGi (D) and LC (F). Cannulated animals were habituated for 4 days (Hab) and some of them were trained in the OR task. Some animals were not exposed to OR apparatus (Naïve controls). Trained animals rats were exposed to two different objects for 5 min and immediately after that received bilateral infusions of saline (Sal) or muscimol (MUS) in NTS, PGi (0.01 lg/ll; 0.5 ll/side) or LC (0.02 lg/ll; 0.25 ll/side). 120 min after that, the animals are killed by decapitation, the dorsal CA1 region of hippocampus dissected out and total homogenates submitted to SDS-PAGE followed by immunoblot analysis with antibodies against BDNF (A, C and E) or tubulin (B, D and F) . Bars show the percentage levels respect to naive animals. Data are expressed as mean ± SD.
⁄ P 6 0.05 in Dunnett's comparison test after ANOVA; n = 5 per group.
OR training is accompanied by an increase of norepinephrine levels on hippocampus, which is impaired by NTS-PGi-LC pathway inactivation
Sixteen animals were divided in four groups: (i) Naïve (n = 4); (ii) Habituated, which rats were just habituated to OR apparatus (Hab) (n = 4); (iii) Saline (Sal), which rats were trained in OR task and received a saline infusion in NTS (n = 4); and (iv) muscimol (MUS), which rats were trained in OR task and received a MUS infusion in NTS (n = 4). Rats from group (ii), (iii) and (iv) were euthanized for hippocampus dissection 15 min later the last behavioral procedure. The CA1 regions of both dorsal hippocampi were homogenized and processed for HPLC determination of NE levels. The rats that received Sal presented an increase of hippocampal NE levels when compared to Naïve and Saline groups (P < 0.01). Inactivation of the NTS-PGi-LC pathway by MUS infusion into NTS blocked this increase (Fig. 4 , P < 0.01).
OR training culminates in an increase of BDNF expression on hippocampus which is impaired by inactivation of the NTS-PGi-LC pathway and reversed by norepinephrine injection on hippocampus and by LC stimulation with NMDA
We verified that inactivation of NTS (Fig. 5A) , PGi (Fig. 5C) or LC (Fig. 5E) with MUS blocked the BDNF increase that occurred 120 min post training in the OR task (P = 0.02 for NTS, PGi and LC). We also measured the tubulin levels as a control procedure and did not find any differences between groups (Fig. 5B , D and F) (P > 0.05 in all analyses).
Importantly, the infusion of NE in CA1 region immediately after infusion of MUS in NTS (Fig. 6A) , PGi (Fig. 6C) or LC (Fig. 6E ) reverts the effect previously described, and permits the increase of BDNF expression 120 min post training in OR (P = 0.01 to NTS and PGi; P = 0.02 to LC). There are no differences between groups in tubulin levels (Fig. 6B , D and F) (P > 0.05 in all analyses).
Also, stimulation of LC with NMDA after MUS injection in NTS (Fig. 7A) or PGi (Fig. 7C) reverts the block of the increase of BDNF expression 120 min after training in OR (P = 0.02 to NTS and PGi). There are no differences between groups in tubulin levels ( Fig. 7B and D) (P > 0.05 in all analyses).
Discussion
This study provides important complementary evidence about the role of hippocampal NE in OR consolidation (Mello-Carpes & Izquierdo, 2013) . In the first set of experiments we show that hippocampal NE acting on b-adrenergic receptors is necessary to OR memory consolidation, since the injection of timolol (a b-blocker) after OR training impairs memory consolidation. Otherwise, the injection of NE just after OR learning, although it did not affect Fig. 6 . Block of the increase of BDNF by infusion of muscimol in NTS (A), PGi (C) and LC (E) are reversed by infusion of NE in CA1 region of dorsal hippocampus. The infusion of muscimol in NTS (B), PGi (D) and LC (F) followed by infusion of NE in CA1 region of dorsal hippocampus did not alter tubulin protein levels 120 min after training. After the cannula implantation procedure, animals were divided into naïve controls and animals trained in the OR task. Trained rats were exposed to two different objects for 5 min and immediately after that received bilateral infusions of saline (Sal) or muscimol (MUS) into NTS, PGi (0.01 lg/ll; 0.5 ll/side) or LC (0.02 lg/ll; 0.25 ll/side) + norepinephrine (NE) in CA1 (1 lg/ll; 1 ll/side). One-hundred-and-twenty min after that, they were killed by decapitation, the dorsal CA1 region of hippocampus dissected out and total homogenates were submitted to SDS-PAGE followed by immunoblot analysis with antibodies against BDNF (A, C and E) or tubulin (B, D and F) . Bars show the percentage levels respect to naive animals. Data are expressed as mean ± SD.
⁄ P 6 0.05 in Dunnett's comparison test after ANOVA; n = 5 per group. memory consolidation by itself, promoted memory persistence, since the rats that received NE could remember the original memory for at least 21 days, while the controls did not. Other authors also demonstrated that noradrenergic activation influences the consolidation of OR memory tasks. (Dornelles et al., 2007) used systemic injections of epinephrine which promoted memory improvement, an effect that could be blocked by prior propranolol administration. Roozendaal et al. (2008) provided evidences that the post training BLA norepinephrine administration promotes a dose dependent enhancement of OR memory, while propranolol administration promotes a dose dependent OR memory impairment. The authors concluded that a post training noradrenergic BLA activation can enhance a low-arousing experience, inducing LTM consolidation. Taken together with those previous data, our results suggest that hippocampal NE is essential for OR memory consolidation and its release depends on activation of the NTS-PGi-LC pathway. Activation of this pathway is presumably related to the presentation of a novelty to the animal (the objects during the OR task training), which would promote an alert state (King & Williams, 2009 ) and stimulate peripheral arousal. The modulatory action of various peripheral hormones and drugs in memory consolidation is well known (Izquierdo et al., 2006; Izquierdo & Medina, 1997; McGaugh, 2000) . The brainstem NTS receives peripheral information and various stimuli from the periphery, and thus, plays a vital role in transmitting these information to the limbic structures that participate in mnemonic processes (Clayton and Williams 2000a,b) . Miyashita and Williams (2004) observed an increase of NE in rat hippocampus after a peripheral injection of epinephrine; this increase did not occur when NTS was inhibited, what suggests that the inhibition of the NTS activity interrupts the transmission of information from the periphery to the hippocampus (Miyashita & Williams, 2004) . The NTS projects to the PGi (Babstock & Harley, 1992) and LC (Takigawa & Mogenson, 1977) , the largest noradrenergic input to hippocampus (Haring & Davis, 1985; Loughlin, Foote, & Grzanna, 1986; Loy, Koziell, & Moore, 1980) . McGaugh and colleagues had studied the role of the NTS-PGi-LC pathway in the consolidation of emotional memories (McGaugh, 2000; Williams & McGaugh, 1993) and demonstrated that peripheral injection of epinephrine improves the retention of aversive memory. Here, the infusion of NE directly into the CA1 region of hippocampus immediately after training did not affect the consolidation of recognition memory when compared to control animals. It is difficult to observe memory enhancement in the OR task protocol used here, since memory is usually at the measurable maximum. Moreover, even if the exogenous injection of NE in the hippocampus after learning has not improved OR memory, tests up to 21 days after the training showed that the animals that received NE, unlike the controls, remain with the ability to discriminate the familiar and the new object, which is viewed as an increase of persistence. Since, as discussed by McGaugh (2000 McGaugh ( , 2015 , enhanced persistence is usually the result of enhanced consolidation, it is probably legitimate to infer that when the former is seen the latter had taken place (McGaugh, 2000 (McGaugh, , 2015 .
It is important to consider that different protocols to evaluate OR memory are currently used. The nature of the protocol certainly could influence the results observed and this could make it difficult to draw conclusions on the role of each structure and neurotransmitter system in OR. Whether or not OR memory consolidation requires the hippocampus, for example seems to depend on the version of the task used (see reviews: Ameen-Ali, Easton, and Eacott, 2015 and , Cohen and Stackman Jr., 2015) . An interesting work form Balderas et al. (2015) differentiates the role of hippocampus in object and object-in-context memory tasks. AmeenAli et al. (2015) conclude that the contribution of hippocampus in OR memory is not so clear, but evidence suggests that the hippocampus is involved in integrating object information and spatial Fig. 7 . Blockade of the BDNF increase in CA1 by infusion of muscimol in NTS (A) and PGi (C) are reversed by infusion of NMDA in LC. The infusion of muscimol in NTS (B) and PGi (D) followed by infusion of NMDA in LC did not alter tubulin protein levels 120 min after training. Cannulae implanted animals were either trained in the OR task or left untrained (naïve). Trained animals rats were exposed to two different objects for 5 min and immediately after that received bilateral infusions of saline (Sal) or muscimol (MUS) in NTS or PGi (0.01 lg/ll; 0.5 ll/side) + NMDA in LC (0.01 lg/ll; 0.25 ll/side). 120 min after that, the animals are killed by decapitation, the dorsal CA1 region of hippocampus dissected out and total homogenates submitted to SDS-PAGE followed by immunoblot analysis with antibodies against BDNF (A and C) or tubulin (B and D). Bars show the percentage levels respect to naive animals. Data are expressed as mean ± SD.
⁄ P 6 0.05 in Dunnett's comparison tests after ANOVA; n = 5 per group.
and contextual information, which permits the formation of episodic memories. Additionally, some details of task procedures that vary between different labs can influence results. The use of habituation, the use of identical or different objects on OR training session (Dornelles et al., 2007) and the duration of training session (Roozendaal et al., 2008) are factors that could influence the results obtained. In our case, using the standard 4 days of habituation and a 5 min training session with two different objects, we verify that OR memory consolidation requires hippocampal noradrenaline, and OR learning promotes increase of NE levels, which is blocked by NTS-PGi-LC pathway inactivation through muscimol injection on NTS. This results agree with the hypothesis that OR task promotes NTS-PGi-LC-CA1 activation, what culminates with NE release in hippocampus, essential to this memory consolidation.
There is evidence about the involvement of BDNF on memory consolidation and persistence (Bekinschtein et al., 2007; Bekinschtein et al., 2008; Romero-Granados et al., 2010; Slipczuk et al., 2009 ). In our third set of experiments we investigated the BDNF protein expression on hippocampus after OR learning and our results agree with Furini et al. (2010) , demonstrating that 120 min after training in the task of OR there is an increase in BDNF expression in the CA1 region of the dorsal hippocampus. As previously demonstrated, the inactivation of NTS, PGi or LC blockers the learning in OR task (Mello-Carpes & Izquierdo, 2013) ; also, here we verified that the inactivation of any of this brainstem nucleus also avoids BNDF increase in hippocampus. The infusion of exogenous noradrenaline in hippocampus (CA1) after NTS, PGi or LC inhibition allowed the BDNF increase (and the OR learning, as showed by Mello-Carpes & Izquierdo, 2013) . Additionally, proving the pathway organization, the NTS or the PGi inactivation combined with the subsequently activation of a downstream point of the pathway (by NMDA injection on LC) also allowed the BDNF increase.
Both b-noradrenergic mechanisms, probably hippocampal (Parfitt, Barbosa, Campos, Koth, & Barros, 2012) , and BDNFmediated hippocampal mechanisms (Bekinschtein et al., 2008) have been attributed a role in the persistence of fear-motivated learning in rats. The present data endorse both postulations, and extend them to OR, a non-aversive, more ''cognitive" behavior. Further, they suggest that the effects on persistence are initiated at the time of consolidation, as most data on the role of the latter on persistence show (Furini, Myskiw, & Izquierdo, 2014; McGaugh, 2000 McGaugh, , 2015 . In addition, they point to an involvement of the NTS-PGi-LC-CA1 pathway proposed by McGaugh, Williams and their coworkers in aversive tasks (Clayton and Williams, 2000a,b; Miyashita & Williams, 2004; Williams & McGaugh, 1993 ) and more recently also by us in OR (Mello-Carpes & Izquierdo, 2013) to regulate memory consolidation by noradrenergic endings in the hippocampus and amygdala.
